iih glp-1 medications and pseudotumor cerebri / idiopathic intracranial hypertension #pseudotumorcerebri #iih The effect of glucagon-like peptide-1

The results of the risk of bias assessment are summarized in the Table S7

Keep a brief log of vomiting episodes and pill timing if you experience GI upset

Iwilfin, an orally available inhibitor of ornithine decarboxylase, was approved based on the results of a single-arm study of children with HRNB who were initially treated with standard regimens, including immunotherapy

Cuthbertson DJ, Irwin A, Gardner CJ, Daousi C, Purewal T, Furlong N, et al

Smaller meals and snacks are often easier to tolerate and easier to repeat consistently

A weight loss plateau during tirzepatide therapy is a common phenomenon where weight reduction slows significantly or stops despite continued medication adherence